Oryzon Genomics S.A. ( ORYZF) - Stock Earnings

ORYZF Upcoming earnings

Estimated EPS and revenue columns are available to paid members.

Date EPS (actual / est.) Revenue low (est.) Revenue (actual / est.) Revenue high (est.)
Nov. 6, 2026, midnight — / — — — / — —

ORYZF Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -1.6 million USD — USD
2026Q1 -1.4 million USD — USD
2026Q2 -158521 USD — USD
2026Q4 Est. — —
2027Q1 Est. — —
2027Q2 Est. — —

ORYZF Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -3.7 million USD 15.7 million USD
2024 -3.8 million USD 7.7 million USD
2025 -3.1 million USD — USD
2026 Est. — —

ORYZF

Price: $3.10

52 week price:
3.10
3.70

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 253.9 million

Links: